Vice President, Ophthalmology Medical Affairs

Annexon Biosciences

2 days ago

3.5 on Glassdoor

San Francisco Bay Area

Onsite

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Vice President, Ophthalmology Medical Affairs at Annexon Biosciences will represent the company with external thought leaders and drive global medical affairs activities in ophthalmology. The role involves leading medical strategy, managing medical affairs operations, and collaborating with internal and external stakeholders.

Skills

Qualifications

Advanced degree (MD, PhD, or PharmD) preferred

About Annexon Biosciences

annexonbio.com

Annexon Biosciences is a biopharmaceutical company developing next‑generation complement therapies by targeting C1q, the initiating molecule of the classical complement pathway. By blocking C1q, Annexon aims to prevent downstream immune‑mediated damage in autoimmune, neurodegenerative (including Alzheimer’s and Huntington’s) and ophthalmic diseases affecting the body, brain, and eye. The company advances C1q‑targeted biologics through a pipeline of therapeutic candidates intended to provide disease‑modifying treatments for conditions driven by classical complement activation.

Recent company news

GlobeNewswire

Annexon Biosciences to Present at the TD Cowen 46th Annual Health Care Conference

3 weeks ago

TipRanks

Annexon Biosciences Announces Planned Retirement of Board Chairman

4 weeks ago

Stock Titan

Annexon targeting neuroinflammatory disease, CEO to speak at TD Cowen

3 weeks ago

Investing.com

Annexon Biosciences stock rating reiterated by Cantor Fitzgerald

Jan 14, 2026

Yahoo Finance

Annexon Announces Completion of Enrollment in Pivotal Phase 3 ARCHER II Trial of Vonaprument (formerly ANX007) for Dry Age-Related Macular Degeneration (AMD) with Geographic Atrophy

Jul 24, 2025